Table 3 correlation between KDM6B expression and clinicopathologic characteristics of ESCC patients
From: KDM6B promotes ESCC cell proliferation and metastasis by facilitating C/EBPβ transcription
characteristics KDM6B | KDM6B | ||
|---|---|---|---|
Low or none, no. cases | High, no. cases | P value | |
Age(y) | |||
≥ 60 | 6 | 5 | 0.406 |
< 60 | 12 | 18 | |
Gender | |||
Male | 16 | 22 | 0.409 |
Female | 2 | 1 | |
T classification | |||
T1 | 1 | 0 | 0.233 |
T2 | 8 | 5 | |
T3 | 8 | 15 | |
T4 | 1 | 3 | |
N classification | |||
N0 | 16 | 7 | 0.001 |
N1 | 1 | 12 | |
N2 | 1 | 3 | |
Lymph node Metastasis | |||
No | 16 | 6 | 0.000 |
Yes | 2 | 17 | |
Pathologic differentiation | |||
Low | 1 | 5 | 0.342 |
Medium | 9 | 9 | |
High | 8 | 9 | |